SCHEMBL28679451

SCHEMBL28679451

CN1CCN(CC(=O)NCCOCCN)CC1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
TDP1 Q9NUW8 1/20 0.49
SIGMAR1 Q99720 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.41
KDM4E B2RXH2 5/20 0.40
ALOX15 P16050 1/20 0.40
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
ATM Q13315 2/20 0.37
RECQL P46063 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP2C19 P33261 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12705102 0.92 ALDH1A1 (0.51) ALDH1A1TDP1SIGMAR1SMN1; SMN2KDM4E
SCHEMBL18545056 0.87 ALDH1A1 (0.48) ALDH1A1TDP1SIGMAR1SMN1; SMN2KDM4E
SCHEMBL20610685 0.85 ALDH1A1 (0.46) ALDH1A1TDP1SIGMAR1SMN1; SMN2KDM4E
SCHEMBL11952855 0.84 SIGMAR1 (0.54) ALDH1A1TDP1SIGMAR1SMN1; SMN2KDM4E
SCHEMBL12942964 0.83 ALDH1A1 (0.53) ALDH1A1TDP1SIGMAR1SMN1; SMN2KDM4E
SCHEMBL12906773 0.83 ALDH1A1 (0.53) ALDH1A1TDP1SIGMAR1SMN1; SMN2KDM4E
SCHEMBL12906765 0.83 ALDH1A1 (0.53) ALDH1A1TDP1SIGMAR1SMN1; SMN2KDM4E
SCHEMBL12906769 0.83 ALDH1A1 (0.53) ALDH1A1TDP1SIGMAR1SMN1; SMN2KDM4E
SCHEMBL12906774 0.83 ALDH1A1 (0.53) ALDH1A1TDP1SIGMAR1SMN1; SMN2KDM4E
SCHEMBL21440842 0.83 ALDH1A1 (0.47) ALDH1A1TDP1SIGMAR1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113195498-A Novel imidazopyrazine derivatives 豪夫迈·罗氏有限公司 2021-07-30 CN disclosed